Q-Line Biotech Schedules Board Meeting for 16th AGM Approvals and Cost Auditor Appointment
Q-Line Biotech Ltd 路 Others (Uncategorized) 路 05 Sept 2026, 12:39 am
Q-Line Biotech Schedules Board Meeting for 16th AGM Approvals and Cost Auditor Appointment Q-Line Biotech Limited has scheduled a Board of Directors meeting on 5th Sep'26 to consider and approve key corporate actions. The agenda includes approving the Directors' Report for the financial year ended 31st Mar'26, finalising the notice and schedule for the 16th Annual General Meeting, fixing the cut-off date for e-voting, and recommending director appointments. Additionally, the board will evaluate the appointment and remuneration of M/s P S P & Associates as Cost Auditor for FY 2026-27, subject to shareholder ratification.
Original exchange filing (PDF)
More announcements from Q-Line Biotech Ltd
- Q-Line Biotech Limited has informed the Exchange regarding 'Submission of audio recording of Earnings Conference Call-13.11.2026'. 路 15 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Investor Presentation 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about General Updates 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding a press release dated November 12, 2026, titled "PRESS RELEASE ON FINANCIAL RESULTS 30 SEPTEMBER 2026.". 路 13 Nov 2026
- Q-Line Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'. 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Schedule of meet 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 12 Nov 2026
